Posts

Toward useful interpretability in Ten years: What level of understanding of neural networks is realistically achievable?

Toward Useful Interpretability in Ten Years Hello, I have written some interesting articles that are related to my subject of today , and here they are in the following web links, and hope that you will read them carefully: The AI Echo Chamber: Why Artificial Intelligence needs human creativity to survive https://myphilo10.blogspot.com/2026/03/the-ai-echo-chamber-why-artificial_14.html In-Memory computing with MRAM: A realistic path toward 50× efficiency gains in Artificial Intelligence systems https://myphilo10.blogspot.com/2026/04/in-memory-computing-with-mram-realistic.html Distributed intelligence in neural architectures: Manifolds, activation dynamics, and the shift from symbols to geometry https://myphilo10.blogspot.com/2026/01/distributed-intelligence-in-neural.html Artificial intelligence, junior software employment, and the myth of structural collapse https://myphilo10.blogspot.com/2025/12/artificial-intelligence-junior-software.html From accurac...

Artificial Intelligence and the future of universal vaccines: A new paradigm for pandemic preparedness

Artificial Intelligence and the Future of Universal Vaccines Hello, I have written some interesting articles that are related to my subject of today , and here they are in the following web links, and hope that you will read them carefully: The Shingles vaccine as a cardiovascular protector: A new paradigm in preventive medicine https://myphilo10.blogspot.com/2026/03/the-shingles-vaccine-as-cardiovascular.html Quantum proteins: A new frontier in biology and medicine https://myphilo10.blogspot.com/2026/03/quantum-proteins-new-frontier-in.html Toward a universal mucosal vaccine against respiratory threats https://myphilo10.blogspot.com/2026/02/toward-universal-mucosal-vaccine.html Human transmission risk of Bat-Borne Orthoreoviruses: A comparative analysis with SARS-CoV-2 https://myphilo10.blogspot.com/2026/02/human-transmission-risk-of-bat-borne.html Toward broad-spectrum antivirals: Activating host defenses to combat diverse viral infections https://myp...

Dietary modulation of hypertension risk: The role of two accessible foods in cardiovascular protection

Dietary Modulation of Hypertension Risk Hello, Today, I present a new paper entitled: "Dietary Modulation of Hypertension Risk: The Role of Two Accessible Foods in Cardiovascular Protection" , and it should be noted that the conclusion states the following: "Hypertension prevention and management are profoundly influenced by dietary patterns. Current evidence strongly supports that simple, everyday foods—specifically legumes and leafy green vegetables—play a significant role in lowering blood pressure and reducing cardiovascular risk. Their effects are biologically mediated through improvements in endothelial function, electrolyte balance, and systemic inflammation, yielding measurable systolic blood pressure reductions. While isolated foods are not a panacea, integrating 1 cup of leafy greens and regular servings of legumes into a broader DASH or Mediterranean-style dietary pattern can reduce cardiovascular risk by up to one-third. Acknowledging...

Long-acting RNA-Based cholesterol therapies: A new frontier in cardiovascular disease prevention

Long-Acting RNA-Based Cholesterol Therapies Hello, Today, I present a new paper entitled: "Long-Acting RNA-Based Cholesterol Therapies: A New Frontier in Cardiovascular Disease Prevention" , and it should be noted that the conclusion states the following: "The development of long-acting RNA-based cholesterol therapies represents one of the most important advances in cardiovascular prevention since the introduction of statins. By targeting PCSK9 production at the genetic messenger level, inclisiran provides sustained reductions in LDL cholesterol while requiring only infrequent administration. Clinical trials have demonstrated robust efficacy, favorable safety profiles, and the potential for greatly improved treatment adherence. Although challenges related to cost and implementation persist, and definitive proof regarding long-term cardiovascular outcome reductions (MACE) is currently awaited via the ORION-4 trial, current evidence suggests that RNA-inter...